Skip to main content

Featured Content

Neurofeedback treatments for attention-deficit/hyperactivity disorder (ADHD) demonstrate medium to large effect sizes and remission rates between 32% and 47%, according to a published study.
Two addiction treatment leaders discuss the industrywide disruption from the COVID-19 crisis and how it is affecting the psyche of providers and patients.
Provisions in the recently signed Coronavirus Aid, Relief, and Economic Security (CARES) Act include funds for SAMHSA programs, small business loans and money for investing in telehealth technology.
Repeated media exposure to the COVID-19 global crisis may be causing psychological distress, warns a commentary published online in the journal Health Psychology.
In this installment of "Coping During COVID-19," Psych Congress Steering Committee member Rakesh Jain, MD, MPH, shares 7 things he has learned during the COVID-19 pandemic.
In this installment of "Coping During COVID-19," Psych Congress Steering Committee members Saundra Jain, MA, PsyD, LPC, and Andrew Penn, RN, MS, NP, CNS, APRN-BC, discuss the professional and personal impacts of the global coronavirus pandemic.
Stress-related disorders, such as post-traumatic stress disorder, are associated with a considerably higher risk of developing neurodegenerative diseases, according to a study published online in JAMA Neurology. 

Meetings & Publications

Back to Top